Ray Dalio says the Fed faces a tough balancing act as the economy faces ‘enormous amount of debt’

Ray Dalio says the Fed faces a tough balancing act as the economy faces ‘enormous amount of debt’


Key Points
  • As the U.S. Federal Reserve implemented its first interest rate cut since the early Covid pandemic, billionaire investor Ray Dalio flagged that the U.S. economy still faces an “enormous amount of debt.”
  • “The challenge of the Federal Reserve is to keep interest rates high enough that they’re good for the creditor, while keeping them not so high that they’re problematic for the debtor,” the founder of Bridgewater Associates told CNBC’s “Squawk Box Asia.”



Source

David Einhorn says the Fed will cut ‘substantially more’ than two times. So he’s betting big on gold
Finance

David Einhorn says the Fed will cut ‘substantially more’ than two times. So he’s betting big on gold

Key Points David Einhorn of Greenlight Capital anticipates the Federal Reserve will cut more than twice in 2026, which is what traders have priced in. Einhorn owns gold and Secured Overnight Financing Rate, or SOFR, futures. Gold has seen massive gains in recent years, though it faced some pressure last month following President Donald Trump’s […]

Read More
Stocks making the biggest moves midday: Acadia Healthcare, Vertiv, Moderna, Unity Software, Generac & more
Finance

Stocks making the biggest moves midday: Acadia Healthcare, Vertiv, Moderna, Unity Software, Generac & more

Check out the companies making headlines in midday trading: Acadia Healthcare — The health-care stock popped 10% after investor David Einhorn told CNBC that he has been buying the stock. The Greenlight Capital fund manager said he’s hopeful the company’s new management will be able to improve its performance. Vertiv — The provider of data […]

Read More
Stocks making the biggest moves premarket: Lyft, Moderna, Cloudflare, Ford, Zillow Group and more
Finance

Stocks making the biggest moves premarket: Lyft, Moderna, Cloudflare, Ford, Zillow Group and more

Check out the companies making headlines before the bell: Moderna — Shares tumbled 10% after the pharma giant said the Food and Drug Administration refused to review its application for an experimental flu shot, mRNA-1010. Moderna said it has requested a meeting with the FDA to “understand the path forward.” Humana — The health insurance company […]

Read More